Hydrazine

Hydrazine

SCHEMBL22634091

Cc1c(C)c(S(=O)(=O)Cl)c(C)c2c1OC(C)(C)CC2.NN

nearest known ligand 0.38

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 2/20 0.38
CYP3A4 P08684 2/20 0.38
PTGS1 P23219 1/20 0.38
PTGS2 P35354 1/20 0.38
TSHR P16473 1/20 0.38
PLG P00747 2/20 0.36
F10 P00742 1/20 0.36
PLAU P00749 1/20 0.36
KLKB1 P03952 1/20 0.36
F2 P00734 1/20 0.33
LMNA P02545 2/20 0.32
CCR5 P51681 1/20 0.32
HPGD P15428 1/20 0.32
IDO1 P14902 2/20 0.31
PSEN1 P49768 3/20 0.30
KDM4E B2RXH2 1/20 0.30
MEN1 O00255 1/20 0.30
CES2 O00748 1/20 0.30
GMNN O75496 1/20 0.30
TDP2 O95551 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL838416 0.97 CYP1A2 (0.39) CYP1A2CYP3A4PTGS1PTGS2TSHR
SCHEMBL29402889 0.97 CYP1A2 (0.39) CYP1A2CYP3A4PTGS1PTGS2TSHR
SCHEMBL29400649 0.85 CYP1A2 (0.39) CYP1A2CYP3A4PTGS1PTGS2TSHR
SCHEMBL112491 0.85 CYP1A2 (0.39) CYP1A2CYP3A4PTGS1PTGS2TSHR
SCHEMBL8294965 0.83 CYP1A2 (0.43) CYP1A2CYP3A4PTGS1PTGS2TSHR
SCHEMBL4434438 0.82 CYP1A2 (0.39) CYP1A2CYP3A4PTGS1PTGS2TSHR
SCHEMBL4530181 0.82 PTGS1 (0.42) CYP1A2CYP3A4PTGS1PTGS2TSHR
SCHEMBL8531015 0.82 CYP1A2 (0.39) CYP1A2CYP3A4PTGS1PTGS2TSHR
SCHEMBL29788426 0.82 CYP1A2 (0.39) CYP1A2CYP3A4PTGS1PTGS2TSHR
SCHEMBL17007494 0.81 HSP90AA1 (0.37) CYP1A2CYP3A4PLGPLAUF2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230111252-A1 THIOSEMICARBAZATES AND USES THEREOF THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH (US) 2023-04-13 US disclosed
US-20200354318-A1 THIOSEMICARBAZATES AND USES THEREOF THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH (US) 2020-11-12 US disclosed
WO-2020227592-A1 THIOSEMICARBAZATES AND USES THEREOF THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH (US) 2020-11-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230111252-A1 THIOSEMICARBAZATES AND USES THEREOF TST, ABAT, AADAC CYP1A2 3108/4885CYP3A4 1598/4885PTGS1 4428/4885
US-20200354318-A1 THIOSEMICARBAZATES AND USES THEREOF TST, ABAT, AADAC CYP1A2 3108/4885CYP3A4 1598/4885PTGS1 4428/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.